EganT.D., ShaferS.L.Target-controlled infusions for intravenous anesthetics: surfing USA not!Anesthesiology2003; 99: 1039–1041.
2.
EnlundM.Target controlled infusion, or totally confused infusion? Call for an optimised population based pharmacokinetic model for propofol.Ups J Med Sci2008; 113: 161–170.
3.
AbsalomA.R., ManiV., De SmetT., StruysM.M.Pharmacokinetic models for propofol-defining and illuminating the devil in the detail.Br J Anaesth2009; 103: 26–37.
4.
CrankshawD.P., BrownM.J., BjorkstenA.R.A comparison of parametric and non-parametric approaches to target-controlled infusion of propofol.Anaesth Intensive Care2010; 38: 3: xx-437–444.
5.
CrankshawD.P., EdwardsN.E., BlackmanG.L., BoydM.D., ChanH.N., MorganD.J.Evaluation of infusion regimens for thiopentone as a primary anaesthetic agent.Eur J Clin Pharmacol1985; 28: 543–552.
6.
CrankshawD.P., BoydM.D., BjorkstenA.R.Plasma drug effluxa new approach to optimization of drug infusion for constant blood concentration of thiopental and methohexital.Anesthesiology1987; 67: 32–41.
7.
SwinhoeC.F., PeacockJ.E., GlenJ.B., ReillyC.S.Evaluation of the predictive performance of a ‘Diprifusor’ TCI system.Anaesthesia1998; 53: 61–67.
8.
HoymorkS.C., RaederJ., GrimsmoB., SteenP.A.Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery.Br J Anaesth2003; 91: 773–780.
9.
VarvelJ.R., DonohoD.L., ShaferS.L.Measuring the predictive performance of computer-controlled infusion pumps.J Pharmacokinet Biopharm1992; 20: 63–94.
10.
MintoC.F., SchniderT.W., EganT.D., YoungsE., LemmensH.J., GambusP.L.Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.Anesthesiology1997; 86: 10–23.
11.
IohomG., Ni ChonghaileM., O'BrienJ.K., CunninghamA.J., FitzgeraldD.F., ShieldsD.C.An investigation of potential genetic determinants of propofol requirements and recovery from anaesthesia.Eur J Anaesthesiol2007; 24: 912–919.
FukudaK., HayashidaM., IdeS., SaitaN., KokitaY., KasaiS.Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery.Pain2009; 147: 194–201.
14.
RehbergB., RyllC., HadzidiakosD., BaarsJ.Use of a target-controlled infusion system for propofol does not improve subjective assessment of anaesthetic depth by inexperienced anaesthesiologists.Eur J Anaesthesiol2007; 24: 920–926.
15.
SongD., JoshiG.P., WhiteP.F.Titration of volatile anesthetics using bispectral index facilitates recovery after ambulatory anesthesia.Anesthesiology1997; 87: 842–848.
16.
RecartA., GasanovaI., WhiteP.F., ThomasT., OgunnaikeB., HamzaM.The effect of cerebral monitoring on recovery after general anesthesia: a comparison of the auditory evoked potential and bispectral index devices with standard clinical practice.Anesth Analg2003; 97: 1667–1674.
17.
MonkT.G., SainiV., WeldonB.C., SiglJ.C.Anesthetic management and one-year mortality after noncardiac surgery.Anesth Analg2005; 100: 4–10.
18.
LindholmM-L, TraffS., GranathF., GreenwaldS.D., EkbomA., LennmarkenC.Mortality within 2 years after surgery in relation to low intraoperative bispectral index values and preexisting malignant disease.Anesth Analg2009; 108: 508–512.
19.
BillardV., ServinF.Light or deep general anaesthesia: does it matter and how to assess it?Eur J Anaesthesiol2008; 25: 781–783.
20.
LeslieK., MylesP.S., ForbesA., ChanM.T.V.The effect of bispectral index monitoring on long-term survival in the B-aware trial.Anesth Analg2010; 110: 816–822.
21.
MylesP.S., LeslieK., McNeilJ., ForbesA., ChanM.T.V.Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial.Lancet2004; 363: 1757–1763.
22.
EkmanA., LindholmM-L, LennmarkenC., SandinR.Reduction in the incidence of awareness using BIS monitoring.Acta Anaesthesiol Scand2004; 48: 20–26.
23.
AvidanM.S., ZhangL., BurnsideB.A., FinkelK.J., SearlemanA.C., SelvidgeJ.A.Anesthesia awareness and the bispectral index.N Engl J Med2008; 358: 1097–1108.
24.
PunjasawadwongY., PunjasawadwongA., BunchungmongkolN.Bispectral index for improving anaesthetic delivery and postoperative recoveryCochrane Database of Systematic Reviews,2007.
25.
DexterF., BaymanE.O., EpsteinR.H.Statistical modeling of average and variability of time to extubation for meta-analysis comparing desflurane to sevoflurane.Anesth Analg2010; 110: 570–580.
26.
GlassP.S.Anesthetic drug interactions: an insight into general anesthesia – its mechanism and dosing strategies.Anesthesiology1998; 88: 5–6.
27.
JohnsonK.B., SyroidN.D., GuptaD.K., ManyamS.C., EganT.D., HuntingtonJ.An evaluation of remifentanil propofol response surfaces for loss of responsiveness, loss of response to surrogates of painful stimuli and laryngoscopy in patients undergoing elective surgery.Anesth Analg2008; 106: 471–479.
28.
SyroidN.D., JohnsonK.B., PaceN.L., WestenskowD.R., TylerD., BruhschweinF.Response surface model predictions of emergence and response to pain in the recovery room: an evaluation of patients emerging from an isoflurane and fentanyl anesthetic.Anesth Analg2010. Epub October 9, 2009 doi: 10.1213/ANE.0b013e3181afe31c Accessed 22 Feb 2010.
29.
SchumacherP.M., DosscheJ., MortierE.P., LuginbuehlM., BouillonT.W., StruysMMRFResponse surface modeling of the interaction between propofol and sevoflurane.Anesthesiology2009; 111: 790–804.
30.
LeslieK., AbsalomA., KennyG.N.C.Closed loop control of sedation for colonoscopy using the Bispectral Index.Anaesthesia2002; 57: 693–697.
31.
De SmetT., StruysMMRF, NeckebroekM.M., Van den HauweK., BonteS., MortierE.P.The accuracy and clinical feasibility of a new bayesian-based closed-loop control system for propofol administration using the bispectral index as a controlled variable.Anesth Analg2008; 107: 1200–1210.